Measurement of chemosensory function
Although hundreds of thousands of patients seek medical help annually for disorders of taste and smell, relatively few medical practitioners quantitatively test their patients' chemosensory function, taking their complaints at face value. This is clearly not the approach paid to patients compla...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bae56df9aed6406d8828c198739229ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bae56df9aed6406d8828c198739229ca |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bae56df9aed6406d8828c198739229ca2021-12-02T14:14:23ZMeasurement of chemosensory function2095-881110.1016/j.wjorl.2018.03.001https://doaj.org/article/bae56df9aed6406d8828c198739229ca2018-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881118300222https://doaj.org/toc/2095-8811Although hundreds of thousands of patients seek medical help annually for disorders of taste and smell, relatively few medical practitioners quantitatively test their patients' chemosensory function, taking their complaints at face value. This is clearly not the approach paid to patients complaining of visual, hearing, or balance problems. Accurate chemosensory testing is essential to establish the nature, degree, and veracity of a patient's complaint, as well as to aid in counseling and in monitoring the effectiveness of treatment strategies and decisions. In many cases, patients perseverate on chemosensory loss that objective assessment demonstrates has resolved. In other cases, patients are malingering. Olfactory testing is critical for not only establishing the validity and degree of the chemosensory dysfunction, but for helping patients place their dysfunction into perspective relative to the function of their peer group. It is well established, for example, that olfactory dysfunction is the rule, rather than the exception, in members of the older population. Moreover, it is now apparent that such dysfunction can be an early sign of neurodegenerative diseases such as Alzheimer's and Parkinson's. Importantly, older anosmics are three times more likely to die over the course of an ensuring five-year period than their normosmic peers, a situation that may be averted in some cases by appropriate nutritional and safety counseling. This review provides the clinician, as well as the academic and industrial researcher, with an overview of the available means for accurately assessing smell and taste function, including up-to-date information and normative data for advances in this field. Keywords: Smell, Taste, Psychophysics, Age, Identification, Detection, Threshold, Olfaction, Anosmia, Ageusia, Hyposmia, HypogeusiaRichard L. DotyKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 4, Iss 1, Pp 11-28 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Otorhinolaryngology RF1-547 Surgery RD1-811 |
spellingShingle |
Otorhinolaryngology RF1-547 Surgery RD1-811 Richard L. Doty Measurement of chemosensory function |
description |
Although hundreds of thousands of patients seek medical help annually for disorders of taste and smell, relatively few medical practitioners quantitatively test their patients' chemosensory function, taking their complaints at face value. This is clearly not the approach paid to patients complaining of visual, hearing, or balance problems. Accurate chemosensory testing is essential to establish the nature, degree, and veracity of a patient's complaint, as well as to aid in counseling and in monitoring the effectiveness of treatment strategies and decisions. In many cases, patients perseverate on chemosensory loss that objective assessment demonstrates has resolved. In other cases, patients are malingering. Olfactory testing is critical for not only establishing the validity and degree of the chemosensory dysfunction, but for helping patients place their dysfunction into perspective relative to the function of their peer group. It is well established, for example, that olfactory dysfunction is the rule, rather than the exception, in members of the older population. Moreover, it is now apparent that such dysfunction can be an early sign of neurodegenerative diseases such as Alzheimer's and Parkinson's. Importantly, older anosmics are three times more likely to die over the course of an ensuring five-year period than their normosmic peers, a situation that may be averted in some cases by appropriate nutritional and safety counseling. This review provides the clinician, as well as the academic and industrial researcher, with an overview of the available means for accurately assessing smell and taste function, including up-to-date information and normative data for advances in this field. Keywords: Smell, Taste, Psychophysics, Age, Identification, Detection, Threshold, Olfaction, Anosmia, Ageusia, Hyposmia, Hypogeusia |
format |
article |
author |
Richard L. Doty |
author_facet |
Richard L. Doty |
author_sort |
Richard L. Doty |
title |
Measurement of chemosensory function |
title_short |
Measurement of chemosensory function |
title_full |
Measurement of chemosensory function |
title_fullStr |
Measurement of chemosensory function |
title_full_unstemmed |
Measurement of chemosensory function |
title_sort |
measurement of chemosensory function |
publisher |
KeAi Communications Co., Ltd. |
publishDate |
2018 |
url |
https://doaj.org/article/bae56df9aed6406d8828c198739229ca |
work_keys_str_mv |
AT richardldoty measurementofchemosensoryfunction |
_version_ |
1718391748008345600 |